Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03905447
Recruitment Status : Terminated (The study is being terminated early as a result of the coronavirus (COVID-19) outbreak.)
First Posted : April 5, 2019
Last Update Posted : June 12, 2020
Sponsor:
Information provided by (Responsible Party):
Pulmocide Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 1, 2020
Actual Study Completion Date : June 1, 2020